ACE and sarcoidosis: In 2021, a novel ACE fingerprinting approach was introduced, utilizing a panel of mAbs and plasma samples to explore the possibility that elevated ACE levels in patients are due to mutations in the ACE gene rather than being related to sarcoidosis [61].